YO21 - Intra-Pericardial Chemotherapy for Pericardial Effusion in Soft Tissue Sarcoma of Lung: A Case Report

Case summary

Pericardial effusion secondary to malignancy is a critical complication that can significantly impact patient outcomes. This case report details the management of a 42-year-old female with a known history of soft tissue sarcoma of the lung, who developed pericardial effusion as a complication of her underlying malignancy. Initially stabilized with a pericardial window and pericardiocentesis, the patient underwent intra-pericardial chemotherapy with Bleomycin, administered once daily for five days. This intervention resulted in a significant reduction in the pericardial effusion, allowing for the successful closure of the pericardial window. The patient continues to receive palliative chemotherapy for her primary disease. This case highlights the efficacy of intra-pericardial chemotherapy in managing pericardial effusion secondary to soft tissue sarcoma, providing a potential therapeutic option for similar cases.

Clinical trial identification

Editorial acknowledgement